RIGHT for patient outcomes
 

Cepheid Xpert® Xpress Strep A

Rapid, Quality Results. No Compromise.

The Need

  • Accurately diagnose pharyngitis caused by Group A Streptococcus (GAS).
  • Reduce overuse of antibiotics for the treatment of pharyngitis.

The Solution

  • On-demand PCR testing for Group A Strep in as soon as 18 minutes.1
  • Careful selection of the target gene produces quality results.
  • Accurate and timely results enable fast treatment decisions and eliminate the need to perform culture confirmation of negative results.2

The Impact

  • Accurately diagnose GAS to support antimicrobial stewardship and may reduce the number of patients who are inappropriately prescribed antibiotics.
  • Gain testing efficiencies and reduce costs by eliminating culture confirmation testing.3
  • Reduce the risk of GAS complications such as rheumatic fever and glomerulonephritis.
  • Improve patient satisfaction with quicker time to result and appropriate prescriptions.
 

Prepare for flu season with Cepheid’s trio of respiratory tests:

  • Xpert® Xpress Flu/RSV
  • Xpert® Xpress Flu
  • Xpert® Xpress Strep A

Cepheid Received FDA Clearance and CLIA Waiver for Xpert® Xpress Flu/RSV, Xpert® Xpress Flu, and Xpert® Xpress Strep A Tests.

US-IVD. For In Vitro Diagnostic Use.

Reference
1. With Early Assay Termination for positive results. Refer to Package Insert Xpert Xpress Strep A 301-6574 Rev. D.
2. Additional follow-up testing by culture is required if the Xpert Xpress Strep A assay result is negative and clinical symptoms persist, or there is an outbreak of acute rheumatic fever (ARF).
3. Workflow studies conducted by Cepheid Solutions demonstrate that a throat culture confirmation workup costs~ $9.13 per culture. (Average cost includes reagents, labor cost and time). Data on file.

About Cepheid

Based in Sunnyvale, California, Cepheid is a leading molecular diagnostics company dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company’s solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases.

Visit www.cepheid.com to view our entire portfolio of molecular diagnostic tests and systems.

Yes, I Want to Learn More!

Please complete the form below and a Cepheid representative will contact you shortly.

By submitting this form, you acknowledge that you have read and agree to Cepheid's privacy policy.